Pathways Longitudinal Projects (PLPs)

The PLPs are a requirement for Worcester-based Pathways. These are longitudinal group initiatives, mentored by a UMass-affiliated PLP faculty mentor, which span across your medical school journey. We require at least 4 learners per PLP. Some PLPs align with multiple Pathways and you will see them listed multiple times.

Please wait until your first Pathways session to learn more about the process of PLP assignments before you reach out to the contacts listed here.

For more information on Pathways, visit: https://www.umassmed.edu/oume/curriculum/Vista-Curriculum/parallel-curricular-programs/Worcester-track/pathways-options/ and refer to the Pathways Handbook.

Select one or more pathways
Title Pathway
Development of a selective PAD2 inhibitor for the treatment of inflammatory disease​ Entrepreneurship, Biomedical Design, and Innovation
Development of Inhibitors Targeting ASC Dependent Inflammasomes Entrepreneurship, Biomedical Design, and Innovation
Development of STING Antagonists: Reversible STING inhibiting compound for treatment of autoimmune disease​ Entrepreneurship, Biomedical Design, and Innovation
Dominican Republic Population, Community, and Global Health
DRIVE (Diversity, Representation, and Inclusion for Value in Education) Pathways Longitudinal Project (PLP) Education, Population, Community, and Global Health, Structural Inequity, Advocacy, and Justice
Dual Inhibitors of Main Protease (MPro) and Cathepsin L as Potent Antivirals against SARS-CoV2 Entrepreneurship, Biomedical Design, and Innovation
Dual-Acting HIV-HTLV Protease Inhibitors Entrepreneurship, Biomedical Design, and Innovation
Earn a Bike: Enchancing community health through bicycles acess and education Structural Inequity, Advocacy, and Justice
Echocardiographic assessment in structural heart procedures Clinical, Community, and Translational Research
Engaging Medical Learners to Build Refugee and Migrant Access, Cultural Humility, and Equity (EMBRACE) Education, Population, Community, and Global Health, Structural Inequity, Advocacy, and Justice, Clinical, Community, and Translational Research